GC

Guillaume CANAUD

A( Assistance Publique—Hôpitaux De Paris (Aphp): 2 patents #140 of 877Top 20%
CN CNRS: 2 patents #1,756 of 11,908Top 15%
IM Inserm (Institut National De La Santé Et De La Recherche Médicale): 2 patents #184 of 1,531Top 15%
UC Université Paris Cité: 2 patents #35 of 608Top 6%
Overall (All Time): #1,739,153 of 4,157,543Top 45%
2
Patents All Time

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDate
12427141 BYL719 (alpelisib) for use in the treatment of PIK3CA-related overgrowth spectrum (PROS-CLOVES syndrome) — 2025-09-30
11433059 BYL719 (alpelisib) for use in the treatment of PIK3CA-related overgrowth spectrum (pros-CLOVES syndrome) — 2022-09-06